Qual é o preço para NuVasive, Inc. (NUVA)

O preço para NuVasive, Inc. (NUVA) é $39.75

Qual é a capitalização de mercado para NuVasive, Inc. (NUVA)

A capitalização de mercado para NuVasive, Inc. (NUVA) é $2.04B

Histórico de Preços de NuVasive, Inc. (NUVA)

NuVasive, Inc. is a medical technology firm focused on creating, producing, and distributing comprehensive procedural solutions for spinal operations. The company offers a range of surgical access instruments, such as the Maxcess integrated split-blade retractor system, which facilitates less-invasive surgical approaches by significantly reducing soft tissue disruption during spinal procedures. Additionally, NuVasive manufactures specialized spinal implants designed to improve spinal fusion by optimizing the osseointegration and biomechanical characteristics of materials like porous titanium and porous polyetheretherketone. Its fixation systems are engineered to help maintain and re-establish proper patient alignment. Other offerings include cervical total disc replacement technology, used in cervical spinal fusion surgery, and advanced neuromonitoring systems. These systems leverage proprietary software for nerve detection and avoidance, complemented by comprehensive intraoperative neuromonitoring services and support. The Pulse platform, a distinctive software ecosystem, unifies various hardware technologies into a compact, integrated system within the operating room environment. Furthermore, NuVasive supplies expandable growing rod implant systems for managing early-onset scoliosis, along with diverse biologics crucial for supporting spinal fusion or bone healing. Another key product is Precice, an intramedullary implant device that employs MAGEC technology for the non-invasive lengthening of the femur and tibia. The company also offers both onsite and remote monitoring solutions for the neurological systems of patients undergoing spinal and brain-related surgical interventions. NuVasive distributes its products to a broad client base, including patients, surgeons, hospitals, and insurers, through a multi-channel sales approach encompassing independent sales agents, its own sales force, and distributors, operating across the United States and global markets. Established in 1997, NuVasive, Inc. maintains its corporate headquarters in San Diego, California.

Ano	Desempenho
2023	-1.64%
2022	-19.81%
2021	1.34%
2020	-34.15%
2019	41.38%
2018	-9.49%
2017	-11.23%
2016	27.51%
2015	12.48%
2014	43.42%
2013	116.59%
2012	18.45%
2011	-47.73%
2010	-21.14%
2009	-12.17%
2008	-15.30%
2007	72.66%
2006	29.02%
2005	90.22%
2004	0.00%

Ano

Desempenho

2023

-1.64%

2022

-19.81%

2021

1.34%

2020

-34.15%

2019

41.38%

2018

-9.49%

2017

-11.23%

2016

27.51%

2015

12.48%

2014

43.42%

2013

116.59%

2012

18.45%

2011

-47.73%

2010

-21.14%

2009

-12.17%

2008

-15.30%

2007

72.66%

2006

29.02%

2005

90.22%

2004

0.00%

Empresa	Preço da ação	Variação 1a%	País
Abbott Laboratories ABT.US	$111.46	-15.21%	US
Stryker Corporation SYK.US	$322.23	-18.04%	US
Medtronic plc MDT.US	$90.06	-2.16%	IE
Boston Scientific Corporation BSX.US	$46.67	-55.92%	US
Siemens Healthineers AG SHL.DE	$46.57	-15.24%	DE

Empresa

Preço da ação

Variação 1a%

País